로딩 중…
지수 로딩 중…
KyungdongPharm
011040· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,060-2.13%
2026-06-19
Price Chart
KyungdongPharm-15.24%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 155.69B KRW |
| Revenue | 198.27B KRW |
| Net Income | 5.97B KRW |
| Total Assets | 309.30B KRW |
| Net Assets | 229.60B KRW |
| Employees | 383 |
| Value | |
| P/E | 26.08x |
| P/B | 0.68x |
| PEG | 0.14x |
| P/S | 0.79x |
| EV/EBITDA | 47.92x |
| FCF Yield | -0.94% |
| Profitability | |
| ROE | 2.60% |
| ROA | 1.93% |
| Op. Margin | 1.74% |
| Revenue Growth | 4.37% |
| Earnings Growth | 187.95% |
| Financial Health | |
| Debt Ratio | 134.71% |
| Total Debt | 25.26B KRW |
| FCF | -1.46B KRW |
| Cash | 15.61B KRW |
| Current Ratio | 1.63x |
| Net Debt/EBITDA | 2.80x |
| Dividend | |
| Div. Yield | 5.80% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -15.24% |
| 1M Return | -4.35% |
| From 52W High | -26.56% |
| 1Y MDD | -21.69% |
| Trading | |
| Volume | 22,336 shares |
| Foreign Own. | 1.81% |
| Per Share | |
| EPS | 378 KRW |
| BPS | 8,240 KRW |
Company Info
Kyungdong Pharm, established in 1976, manufactures and sells pharmaceuticals, specializing in professional medications like circulatory and digestive system agents, and antihypertensive drugs, including products such as Duoroban Tablets and Alfortin Soft Capsules. The company boasts state-of-the-art solid formulation and injectable manufacturing facilities that meet EU-GMP and US c-GMP standards. Leveraging proprietary raw material synthesis and formulation technologies, it achieves continuous revenue growth through combination drug development, increased investment in biotech firms, and the launch of its WIAVIM health functional food brand.